Zbyněk Nový

664 total citations
31 papers, 484 citations indexed

About

Zbyněk Nový is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Zbyněk Nový has authored 31 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Zbyněk Nový's work include Radiopharmaceutical Chemistry and Applications (18 papers), Peptidase Inhibition and Analysis (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Zbyněk Nový is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (18 papers), Peptidase Inhibition and Analysis (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Zbyněk Nový collaborates with scholars based in Czechia, Austria and Germany. Zbyněk Nový's co-authors include Miloš Petřík, Clemens Decristoforo, Marián Hajdúch, Hubertus Haas, Vladimı́r Havlı́ček, Andrea Palyzová, Vladislav Raclavský, Lubor Urbánek, Joachim Pfister and Chuangyan Zhai and has published in prestigious journals such as Advanced Functional Materials, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Zbyněk Nový

28 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zbyněk Nový Czechia 14 197 98 95 90 78 31 484
Anna Helbok Austria 11 221 1.1× 187 1.9× 144 1.5× 155 1.7× 76 1.0× 16 604
Chuangyan Zhai China 11 183 0.9× 45 0.5× 127 1.3× 107 1.2× 41 0.5× 16 408
Leonardo Lima Fuscaldi Brazil 12 179 0.9× 57 0.6× 94 1.0× 83 0.9× 75 1.0× 34 509
Atsushi Shimoyama Japan 17 87 0.4× 68 0.7× 292 3.1× 62 0.7× 59 0.8× 50 674
Philipp René Spycher Switzerland 8 101 0.5× 94 1.0× 122 1.3× 74 0.8× 30 0.4× 18 374
Kuo‐Ting Chen Taiwan 15 85 0.4× 50 0.5× 268 2.8× 55 0.6× 43 0.6× 37 609
Shuping Dou United States 18 457 2.3× 70 0.7× 303 3.2× 130 1.4× 82 1.1× 47 769
Stefan Fischer Switzerland 12 204 1.0× 57 0.6× 285 3.0× 24 0.3× 51 0.7× 15 978
Lyle Burdine United States 14 75 0.4× 61 0.6× 386 4.1× 95 1.1× 21 0.3× 37 708
Mary E. Neville United States 13 53 0.3× 131 1.3× 301 3.2× 84 0.9× 249 3.2× 20 795

Countries citing papers authored by Zbyněk Nový

Since Specialization
Citations

This map shows the geographic impact of Zbyněk Nový's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zbyněk Nový with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zbyněk Nový more than expected).

Fields of papers citing papers by Zbyněk Nový

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zbyněk Nový. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zbyněk Nový. The network helps show where Zbyněk Nový may publish in the future.

Co-authorship network of co-authors of Zbyněk Nový

This figure shows the co-authorship network connecting the top 25 collaborators of Zbyněk Nový. A scholar is included among the top collaborators of Zbyněk Nový based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zbyněk Nový. Zbyněk Nový is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krasulová, Kristýna, et al.. (2025). Positron Emission Tomography Imaging of Acinetobacter baumannii Infection: Comparison of Gallium-68 Labeled Siderophores. ACS Infectious Diseases. 11(4). 917–928.
2.
Vlk, Martin, Ján Kozempel, Zbyněk Nový, et al.. (2025). In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac. EJNMMI Radiopharmacy and Chemistry. 10(1). 16–16.
3.
Krasulová, Kristýna, Zbyněk Nový, Falco Reissig, et al.. (2025). PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression. European Journal of Nuclear Medicine and Molecular Imaging. 53(1). 607–618. 1 indexed citations
4.
Ullrich, Martin, Falco Reissig, Zbyněk Nový, et al.. (2025). It’s a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. EJNMMI Radiopharmacy and Chemistry. 10(1). 31–31.
5.
Schimer, Jiří, Miloš Petřík, Zbyněk Nový, et al.. (2022). Visualization of Sentinel Lymph Nodes with Mannosylated Fluorescent Nanodiamonds. Advanced Functional Materials. 32(23). 24 indexed citations
6.
Reissig, Falco, Kristof Zarschler, Zbyněk Nový, et al.. (2022). Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin. Theranostics. 12(17). 7203–7215. 29 indexed citations
7.
Bárta, Pavel, Zbyněk Nový, Miloš Petřík, et al.. (2022). Preparation, In Vitro Affinity, and In Vivo Biodistribution of Receptor-Specific 68Ga-Labeled Peptides Targeting Vascular Endothelial Growth Factor Receptors. Bioconjugate Chemistry. 33(10). 1825–1836. 4 indexed citations
8.
Reissig, Falco, David Bauer, Kristof Zarschler, et al.. (2021). Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study. Cancers. 13(8). 1974–1974. 40 indexed citations
9.
Nový, Zbyněk, Jiří Janoušek, Pavel Bárta, et al.. (2021). Preclinical evaluation of anti‐VEGFR2 monoclonal antibody ramucirumab labelled with zirconium‐89 for tumour imaging. Journal of Labelled Compounds and Radiopharmaceuticals. 64(7). 262–270. 5 indexed citations
10.
11.
Nový, Zbyněk, Jan Kučka, Miloš Petřík, et al.. (2020). Iodinated Choline Transport-Targeted Tracers. Journal of Medicinal Chemistry. 63(24). 15960–15978. 6 indexed citations
12.
Petřík, Miloš, Vladislav Raclavský, Andrea Palyzová, et al.. (2020). 68Ga-labelled desferrioxamine-B for bacterial infection imaging. European Journal of Nuclear Medicine and Molecular Imaging. 48(2). 372–382. 58 indexed citations
13.
Janoušek, Jiří, et al.. (2019). Antiangiogenic Human Monoclonal Antibody Ramucirumab Radiolabelling:In VitroEvaluation on VEGFR2-positive Cell Lines. Anticancer Research. 39(2). 735–744. 5 indexed citations
14.
Nový, Zbyněk, et al.. (2019). Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme. Molecules. 24(13). 2496–2496. 17 indexed citations
15.
Nový, Zbyněk, Miloš Petřík, Zdeněk Novák, et al.. (2017). Lasioglossins LLIII affect the morphogenesis of Candida albicans and reduces the duration of experimental vaginal candidiasis in mice. Microbiology and Immunology. 61(11). 474–481. 13 indexed citations
16.
Petřík, Miloš, Chuangyan Zhai, Zbyněk Nový, et al.. (2015). In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores. Molecular Imaging and Biology. 18(3). 344–352. 43 indexed citations
17.
18.
Mattová, Jana, P Poučková, Jan Kučka, et al.. (2014). Chelating polymeric beads as potential therapeutics for Wilson’s disease. European Journal of Pharmaceutical Sciences. 62. 1–7. 7 indexed citations
19.
Nový, Zbyněk, Pavel Bárta, Jana Mandíková, Milan Lázníček, & František Trejtnar. (2012). A comparison of in vitro methods for determining the membrane receptor expression in cell lines. Nuclear Medicine and Biology. 39(7). 893–896. 13 indexed citations
20.
Trejtnar, František, Alice Lázníčková, Milan Lázníček, et al.. (2012). Distribution, Elimination, and Renal Handling of 99m Technetium-Demogastrin 1. Cancer Biotherapy and Radiopharmaceuticals. 27(2). 169–174. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Helbok Breakdown of academic impact, for papers by Chuangyan Zhai Breakdown of academic impact, for papers by Leonardo Lima Fuscaldi Breakdown of academic impact, for papers by Atsushi Shimoyama Breakdown of academic impact, for papers by Philipp René Spycher Breakdown of academic impact, for papers by Kuo‐Ting Chen Breakdown of academic impact, for papers by Shuping Dou Breakdown of academic impact, for papers by Stefan Fischer Breakdown of academic impact, for papers by Lyle Burdine Breakdown of academic impact, for papers by Mary E. Neville
Rankless by CCL
2026